Literature DB >> 25092024

[Uveitis in multiple sclerosis : Overview and perspectives].

A L Hildebrandt1, F Mackensen.   

Abstract

The association of uveitis and multiple sclerosis (MS) is less well known than the association between optic neuritis and MS even though MS patients suffer ten times more often from uveitis than the normal population. In this group of patients, intermediate uveitis presenting with periphlebitis and "snowbanks" or "snowballs", as well as granulomatous anterior uveitis play an important role. Simultaneous occurrence of MS and uveitis could be due to the fact that both neural and ocular tissues have the same embryological origin or could be the consequence of an immunological reaction following an Epstein-Barr virus infection. The aim is to find a drug for these patients that treats both MS and uveitis. Currently various studies with different drugs already used successfully in MS patients are under investigation for use in the treatment of uveitis. There is some evidence that interferon beta is effective in macular edema associated with uveitis. Other substances, such as daclizumab, natalizumab and fingolimod also seem to be promising.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25092024     DOI: 10.1007/s00347-013-2984-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  36 in total

1.  Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.

Authors:  S Kurose; E Ikeda; M Tokiwa; N Hikita; M Mochizuki
Journal:  Exp Eye Res       Date:  2000-01       Impact factor: 3.467

Review 2.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

3.  Treatment of autoimmune anterior uveitis with recombinant TCR ligands.

Authors:  Grazyna Adamus; Gregory G Burrows; Arthur A Vandenbark; Halina Offner
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 4.  Fingolimod-associated macular edema: incidence, detection, and management.

Authors:  Nieraj Jain; M Tariq Bhatti
Journal:  Neurology       Date:  2012-02-28       Impact factor: 9.910

Review 5.  Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature.

Authors:  C W Rucker
Journal:  Mayo Clin Proc       Date:  1972-05       Impact factor: 7.616

6.  Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease.

Authors:  Ben J E Raveney; David A Copland; Lindsay B Nicholson; Andrew D Dick
Journal:  Arch Ophthalmol       Date:  2008-10

7.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.

Authors:  Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
Journal:  Arch Ophthalmol       Date:  2003-07

8.  Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis.

Authors:  John H Kempen; Sudha K Ganesh; Virender S Sangwan; Sivakumar R Rathinam
Journal:  Am J Ophthalmol       Date:  2008-08-08       Impact factor: 5.258

9.  Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis.

Authors:  Wojciech A Gorczyca; Maria Ejma; Danuta Witkowska; Marta Misiuk-Hojło; Marianna Kuropatwa; Małgorzata Mulak; Stanisław Szymaniec
Journal:  Ophthalmic Res       Date:  2004 Mar-Apr       Impact factor: 2.892

10.  Multiple sclerosis associated with uveitis in two large clinic-based series.

Authors:  V Biousse; C Trichet; E Bloch-Michel; E Roullet
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  4 in total

1.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

Review 2.  Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Authors:  Taekyun Shin; Meejung Ahn; Jeongtae Kim; Kyungsook Jung; Changjong Moon; Moon-Doo Kim
Journal:  Mol Neurobiol       Date:  2021-03-20       Impact factor: 5.590

3.  Acute Anterior Uveitis in a Patient Taking Fingolimod (FTY720) for Multiple Sclerosis.

Authors:  Heather Gwen Mack; Melissa Chih-Hui Tien; Owen Bruce White
Journal:  Case Rep Ophthalmol       Date:  2016-12-08

4.  Bilateral Anterior and Intermediate Uveitis with Occlusive Vasculitis as Sole Manifestation of Relapse in Multiple Sclerosis.

Authors:  Angelica Pedraza-Concha; Karin Brandauer; Alejandro Tello; Carlos Mario Rangel; Christian Scheib
Journal:  Case Rep Ophthalmol Med       Date:  2019-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.